Category: Disease States

Disease States

CND Life Sciences Secures Growth Financing for Neurodiagnostics Platform

The funding will support the expansion of the Syn-One Test, a skin biopsy-based laboratory developed test for neurodegenerative diseases.

Disease States

10x Genomics and Lausanne University Hospital Collaborate on Cancer Diagnostic Research

10x Genomics and Lausanne University Hospital have begun a multi-year study using single cell and spatial technologies to identify biomarkers predicting treatment response in patients with advanced solid tumors.

Disease States

The Cyclospora Outbreak Is Putting Laboratory Testing to the Test

As Cyclospora infections surge in the US, laboratories face increased pressure to quickly differentiate cases, with the CDC reporting 1,947 confirmed infections and 98 hospitalizations across nine states as of July 24.

Cancer

Labcorp Launches Consumer Genetic Health Panel for Hereditary Risk Assessment

Labcorp has announced the upcoming launch of the Marker by Labcorp Genetic Health Panel, which will analyze 163 genes linked to over 100 medically actionable conditions, with results supported by licensed genetic counselors.

Infectious Diseases

Seegene Proposes New Testing Method for Reproductive Tract Infections

Seegene has introduced a syndromic PCR-based test for simultaneous detection of STIs and HPV. Company data show co-detection in 71% of positive cases, supporting potential clinical utility for comprehensive reproductive infection screening.

Womens Health

Study Supports Multi-Omic Blood Test Strategy for Ovarian Cancer Detection

Researchers identified coordinated lipid, metabolite, and protein signatures in symptomatic patients, supporting a multi-omic strategy for earlier ovarian cancer detection.

Allergy & Autoimmune

Protein Biomarker May Predict Sjögren’s Disease Years Before Symptoms

A new ultrasensitive blood test may detect Sjögren’s disease more than 10 years before symptoms appear by identifying chronically elevated interferon alpha levels in patient blood samples.

Cardiovascular, Cerebrovascular

FDA Clears New Heart Disease Risk Test for Clinical Labs

The assay measures lipoprotein(a) levels in molar units to improve cardiovascular risk assessment and standardization across laboratories.

Dementias & Alzheimer’s

Alzheimer’s Blood Tests Found Effective for Patients with Down Syndrome

USC researchers report that two blood tests, Lumipulse G p-tau217/β-Amyloid 1-42 and PrecivityAD2, can accurately detect Alzheimer’s pathology in patients with Down syndrome.

Diabetes & Metabolic Diseases

Immunoassays May Underestimate HbA1c in Patients with Sickle Cell Trait

Research presented at ADLM 2026 indicates immunoassays may significantly underestimate HbA1c in patients with sickle cell trait, suggesting HPLC offers more reliable diabetes screening for populations with hemoglobin variants.

Kidney Disease

New Study Links Biomarker Elevations to Kidney Transplant Failure Risk

Elevated donor-derived cell-free DNA levels are linked to higher kidney transplant failure risk, suggesting earlier detection of allograft injury before loss of kidney function.

Respiratory Disease

Yourgene Health Cystic Fibrosis Assay Receives IVDR Accreditation

The Cystic Fibrosis Base assay has received IVDR accreditation, ensuring high standards for detecting cystic fibrosis mutations.

Sepsis

FDA Clears New Automated Blood Culture System for Faster Sepsis Detection

The BD BACTEC FXI Culture System reduces detection time for bloodstream infections by approximately three hours compared to previous models.